https://www.selleckchem.com/pr....oducts/cathepsin-Inh
Transplant immunology is currently largely focused on conventional adaptive immunity, particularly T and B lymphocytes, which have long been considered as the only cells capable of allorecognition. In this vision, except for the initial phase of ischemia/reperfusion, during which the role of innate immune effectors is well established, the latter are largely considered as "passive" players, recruited secondarily to amplify graft destruction processes during rejection.Challenging this prevalent dogma, the recent progresses
Like
Comment
Share
